North America Enteral and Parenteral Medical Nutrition Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

No. of Pages: 217    |    Report Code: BMIRE00028875    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Enteral and Parenteral Medical Nutrition Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Enteral and Parenteral Medical Nutrition Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Number of Gastrointestinal Diseases in geriatric population is propelling the market growth
5.2 Market Opportunities
  • 5.2.1 Increasing Cases of Malnutrition and Premature Births in emerging nations is augmenting the demand for enteral and parenteral nutrition products
5.3 Future Trends
  • 5.3.1 Growing Strategic Initiatives by Key Companies
5.4 Impact of Drivers and Restraints

6. North America Enteral and Parenteral Medical Nutrition Market Regional Analysis

6.1 North America Enteral and Parenteral Medical Nutrition Market Overview
6.2 North America Enteral and Parenteral Medical Nutrition Market Revenue 2021-2028 (US$ Million)
6.3 North America Enteral and Parenteral Medical Nutrition Market Forecast Analysis

7. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Indication

7.1 Elderly
  • 7.1.1 Overview
  • 7.1.2 Elderly: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gastrointestinal Disorders
  • 7.2.1 Overview
  • 7.2.2 Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Diabetes
  • 7.3.1 Overview
  • 7.3.2 Diabetes: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer
  • 7.4.1 Overview
  • 7.4.2 Cancer: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Respiratory Disorders
  • 7.5.1 Overview
  • 7.5.2 Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Alzheimer's Disease
  • 7.6.1 Overview
  • 7.6.2 Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Dementia
  • 7.7.1 Overview
  • 7.7.2 Dementia: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Renal Disease
  • 7.8.1 Overview
  • 7.8.2 Renal Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Liver Failure
  • 7.9.1 Overview
  • 7.9.2 Liver Failure: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Post COVID-19
  • 7.10.1 Overview
  • 7.10.2 Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.11 Other Indications
  • 7.11.1 Overview
  • 7.11.2 Other Indications: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Nutrition Type

8.1 Supplemental
  • 8.1.1 Overview
  • 8.1.2 Supplemental: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Sole Source
  • 8.2.1 Overview
  • 8.2.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Form

9.1 Liquid
  • 9.1.1 Overview
  • 9.1.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Powder
  • 9.2.1 Overview
  • 9.2.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Semi Solid
  • 9.3.1 Overview
  • 9.3.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Enteral and Parenteral Medical Nutrition Market – North America Analysis

10.1 North America
  • 10.1.1 North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.1.1.1 North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.1.2 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.1.3 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
  • 10.1.1.2 Canada: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.2.2 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.2.3 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
  • 10.1.1.3 Mexico : North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.3.2 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.3.3 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Enteral and Parenteral Medical Nutrition Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 B. Braun SE
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Baxter International Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Fresenius Kabi AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Medica Nutrition Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Medtrition Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Nestle SA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Nutricia International BV
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Nutrisens SAS
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Enteral and Parenteral Medical Nutrition Market

  1. Abbott Laboratories
  2. B. Braun SE
  3. Baxter International Inc
  4. Fresenius Kabi AG
  5. Medica Nutrition Inc
  6. Medtrition Inc
  7. Nestle SA
  8. Nutricia International BV
  9. Nutrisens SAS